Literature DB >> 22561695

Quantitative evaluation of common polymorphism (rs1801282) in the PPARγ2 gene and hypertension susceptibility.

Yujun Wang1, Chibo Liu.   

Abstract

The peroxisome proliferator-activated receptor-γ2 (PPARγ2) gene has been implicated in the etiology of hypertension. However, the results have been inconsistent. In this study, a meta-analysis was performed to assess the association of PPARγ2 rs1801282 polymorphism with hypertension risk. Published literature from PubMed, Embase databases, CNKI and Wanfang Data were retrieved. Pooled odds ratio (OR) with 95% confidence interval (CI) was calculated using fixed- or random-effects model. Eight studies (1865 cases and 1416 controls) for rs1801282 polymorphism were identified. The results suggested that rs1801282 polymorphism Ala allele might be protective for hypertension among East Asians (Ala/Ala+Pro/Ala vs. Pro/Pro: OR=0.63, 95%CI 0.46-0.86) but not among Caucasians (Ala/Ala+Pro/Ala vs. Pro/Pro: OR=0.72, 95%CI 0.38-1.38). The results indicated the significant association of PPARγ2 rs1801282 polymorphism with hypertension susceptibility among East Asians.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22561695     DOI: 10.1016/j.gene.2012.04.035

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  8 in total

1.  Quantitative evaluation of PPAR-γ2 Pro12Ala polymorphism with hypertension.

Authors:  W Yang; J Wang; W Ye; X Li
Journal:  Herz       Date:  2017-09-18       Impact factor: 1.443

2.  PPARγ2 Pro12Ala polymorphism was associated with favorable cardiometabolic risk profile in HIV/HCV coinfected patients: a cross-sectional study.

Authors:  Pilar García-Broncano; Juan Berenguer; Amanda Fernández-Rodríguez; Daniel Pineda-Tenor; María Ángeles Jiménez-Sousa; Mónica García-Alvarez; Pilar Miralles; Teresa Aldámiz-Echevarria; Juan Carlos López; Dariela Micheloud; Salvador Resino
Journal:  J Transl Med       Date:  2014-08-27       Impact factor: 5.531

3.  Case-control study on peroxisome proliferator-activated receptor gamma polymorphism and interaction with HDL on essential hypertension in Chinese Han.

Authors:  Gang Wang; Ping Xu; Wei Feng; Xianyan Jiang; Tao Zhang; Jian Li
Journal:  Iran J Basic Med Sci       Date:  2015-12       Impact factor: 2.699

4.  The Single Nucleotide Polymorphism PPARG2 Pro12Ala Affects Body Mass Index, Fat Mass, and Blood Pressure in Severely Obese Patients.

Authors:  Ana Paula Dos Santos Rodrigues; Lorena Pereira Souza Rosa; Hugo Delleon da Silva; Elisângela de Paula Silveira-Lacerda; Erika Aparecida Silveira
Journal:  J Obes       Date:  2018-12-12

5.  Association between peroxisome proliferator-activated receptor γ-2 gene Pro12Ala polymorphisms and risk of hypertension: an updated meta-analysis.

Authors:  Miao Zhang; Jianping Zhang; Lifeng Li; Qiang Wang; Limin Feng
Journal:  Biosci Rep       Date:  2019-02-27       Impact factor: 3.840

6.  Associations between PPARG polymorphisms and the risk of essential hypertension.

Authors:  Gaojun Cai; Xinyong Zhang; Weijin Weng; Ganwei Shi; Sheliang Xue; Bifeng Zhang
Journal:  PLoS One       Date:  2017-07-20       Impact factor: 3.240

7.  Pioglitazone Represents an Effective Therapeutic Target in Preventing Oxidative/Inflammatory Cochlear Damage Induced by Noise Exposure.

Authors:  Fabiola Paciello; Anna Rita Fetoni; Rolando Rolesi; Matthew B Wright; Claudio Grassi; Diana Troiani; Gaetano Paludetti
Journal:  Front Pharmacol       Date:  2018-10-08       Impact factor: 5.810

8.  Searching for Factors Raising the Incidence of Metabolic Syndrome Among 45-60-Year-Old Women.

Authors:  Szkup Małgorzata; Brodowski Jacek; Owczarek Aleksander Jerzy; Choręza Piotr; Jurczak Anna; Grochans Elżbieta
Journal:  Aging Dis       Date:  2018-10-01       Impact factor: 6.745

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.